Edwards Lifesciences Aktie
71,96
EUR
+1,71
EUR
+2,43
%
75,09
USD
+1,18
USD
+1,60
%
Edwards Lifesciences Aktie Analyse
16.10.18 | Edwards Lifesciences Underweight | Barclays Capital | |
05.12.12 | Edwards Lifesciences sell | UBS AG | |
15.11.12 | Edwards Lifesciences sell | UBS AG | |
12.04.10 | Edwards Lifesciences verkaufen | Wedbush Morgan Securities Inc. | |
28.07.09 | Edwards Lifesciences underperform | Wedbush Morgan Securities Inc. | |
09.03.07 | Edwards Lifesciences underweight | Morgan Stanley | |
06.02.07 | Edwards Lifesciences Sell | Goldman Sachs | |
06.02.07 | Edwards Lifesciences Sell | Goldman Sachs | |
Werbung
|
|||
14.06.05 | Edwards Lifesciences Underperform | First Albany |